Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels
<p>Abstract</p> <p>Background</p> <p>Alzheimer's disease (AD) is characterized by a decline in cognitive function and accumulation of amyloid-β peptide (Aβ) in extracellular plaques. Mutations in amyloid precursor protein (APP) and presenilins alter APP metabolism...
Main Authors: | Dicker Bridget L, Smithson Lisa, Holloway Vallie, Price Robert W, Das Pritam, Bland Ross J, Lawlor Patricia A, During Matthew J, Young Deborah, Golde Todd E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://www.molecularneurodegeneration.com/content/2/1/11 |
Similar Items
-
Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Aβ immunotherapy
by: Chakrabarty Paramita, et al.
Published: (2006-07-01) -
AAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory.
by: Vicky W K Tsang, et al.
Published: (2014-01-01) -
Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo
by: Das Pritam, et al.
Published: (2011-02-01) -
Effects of AAV-proBDNF on hippocampal DCX positive cells and PSD-95 expression in Alzheimer's disease mice
by: XU Manyu, et al.
Published: (2019-01-01) -
Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
by: Chakrabarty Paramita, et al.
Published: (2012-07-01)